Okyo Pharma Ltd. (OKYO)
Market Closed
15 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
1. 89
-0.17
-8.25%
After Hours
$
+0.17 +8.99% 2. 06
73.34M Market Cap
- P/E Ratio
0% Div Yield
52,654 Volume
0 Eps
$ 2.06
Previous Close Day Range
1.86 2.02
Year Range
0.9 3.35
Want to track OKYO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 7 days
OKYO Pharma shares encouraging dry eye data
OKYO Pharma Ltd (NASDAQ:OKYO) has shared encouraging results from a phase II trial of its treatment candidate for dry eye disease. The study involved 240 patients and showed that 68% of them had improved by meeting both key measures: reduced conjunctival staining and ocular pain.
Proactiveinvestors | 1 year ago
2025 © Marketlog. All Rights Reserved.
